Skip to content

Galactic-Code-Developers/Tri-Modal-Catheter-Lock-TCL

Folders and files

NameName
Last commit message
Last commit date

Latest commit

 

History

29 Commits
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Repository files navigation

Tri-Modal-Catheter-Lock-TCL

Tri-Modal Antifungal Catheter Lock (TCL): Proof of Invention Record

DOI License: CC BY-NC 4.0


Tri-Modal Antifungal Catheter Lock (TCL)

Proof of Invention Record — Kapodistrian Academy of Science

This repository is permanently archived on Zenodo:
🔗 https://doi.org/10.5281/zenodo.17589267


📘 Overview

This repository contains the public disclosure and LaTeX documentation for the Tri-Modal Antifungal Catheter Lock (TCL)
a novel, non-systemic antimicrobial lock formulation designed to eradicate Candidozyma (Candida) auris and other resistant fungal biofilms from indwelling medical devices.

The formulation integrates three synergistic components:

  1. Echinocandin antifungal (e.g., micafungin)
  2. β-1,3-glucanase enzyme (for extracellular matrix digestion)
  3. Gallium(III)/EDTA complex (for iron substitution and metabolic disruption)

Together, these mechanisms collapse the biofilm matrix, inhibit cell-wall synthesis, and block iron metabolism — achieving ≥3-log CFU reduction without damaging catheter materials.


🧪 Scientific Context

  • Inventor: Antonios Valamontes
  • Affiliation: Kapodistrian Academy of Science
  • Collaborating Witness: Dr. Ioannis Adamopoulos — Public Health and Environmental Inspector,
    Department of Environmental Hygiene and Public Health Inspections, Region of Attica, Hellenic Republic.
  • Contact: [email protected]

This repository serves as an official timestamped record of invention for open scientific disclosure and non-commercial academic collaboration.


🔬 Scientific Summary

Mechanism of Action

Component Target Function
Echinocandin (micafungin) β-glucan synthase Disrupts fungal cell wall synthesis
β-1,3-Glucanase Extracellular matrix Liquefies polysaccharide ECM
Ga³⁺ + EDTA Metal metabolism Iron substitution & chelation

This tri-modal mechanism produces a superlinear reduction in residual viability:

$$ \Phi_{\mathrm{TCL}} = \eta_{\mathrm{ech}} \cdot \eta_{\mathrm{enz}} \cdot \left( 1 - \frac{[Fe^{3+}]_{\mathrm{biofilm}}}{[Fe^{3+}]_{0}} \right) $$

Where the combined inhibition terms result in complete matrix collapse and ≥3-log biofilm reduction within 90 minutes.


🧩 Repository Structure

📫 Contact

For collaboration, non-commercial research use, or commercial licensing discussions:

Antonios Valamontes
Kapodistrian Academy of Science
📧 [email protected]


🧾 Acknowledgment

Witnessed and independently verified by
Dr. Ioannis Adamopoulos,
Public Health and Environmental Inspector,
Department of Environmental Hygiene and Public Health Inspections,
Region of Attica, Hellenic Republic.


🧠 Keywords

Candida aurisbiofilmcatheter lockechinocandinβ-1,3-glucanasegalliumEDTAinfection controlpublic health

About

Tri-Modal Antifungal Catheter Lock (TCL): Proof of Invention Record

Resources

Stars

Watchers

Forks

Packages

No packages published